Clinical trialNCT05101551RecruitingPhase 1Interventional

Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy

SponsorNorman J. LacayoEnrollment34Acute Myeloid Leukemia

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Norman Lacayo, MD
Stanford Universiy
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Phoenix Children'S Hospital
Phoenix, Arizona, United States
Laura Retson, DO
Recruiting
Arkansas Children'S Hospital
Little Rock, Arkansas, United States
Kevin J Bielamowicz, MD
Recruiting
City of Hope
Duarte, California, United States
Lindsey Murphy, MD
Recruiting
Stanford University
Stanford, California, United States
Norman LacayoTanja Gruber
Recruiting
Cincinnati Children'S Hospital
Cincinnati, Ohio, United States
Jennifer Kamens, MD
Recruiting
Pennsylvania State University Hershey Medical Center
Hershey, Pennsylvania, United States
Valerie Brown, MD, PhD
Recruiting
St. Jude Children'S Research Hospital
Memphis, Tennessee, United States
Seth Karol, MD
Recruiting
University of Utah
Salt Lake City, Utah, United States
Spencer Mangum, MD
Recruiting
University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, United States
Rebecca Richards, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 23 Feb 2023
Primary completion: 30 Apr 2027
Completion: 30 Apr 2027
Last update posted: 22 Apr 2026
Registered enrollment: 34
Registry id: NCT05101551

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.